Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00083109Phase 2Completed
A Phase 2 trial of suramin in renal cell carcinoma (RCC), sponsored by National Cancer Institute. Started Mar 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00083109.